Centene Corporation(CNC)

Centene Corporation operates as a multi-national healthcare enterprise that provides programs and services to under-insured and uninsured individuals in the United States. Its Managed Care segment offers health plan coverage to individuals through government subsidized programs, including Medicaid, the State children's health insurance program, long-term services and support, foster care, and medicare-medicaid plans, which cover dually eligible individuals, as well as aged, blind, or disabled programs. Its health plans include primary and specialty physician care, inpatient and outpatient hospital care, emergency and urgent care, prenatal care, laboratory and X-ray, home-based primary care, transportation assistance, vision care, dental care, telehealth, immunization, specialty pharmacy, therapy, social work, nurse advisory, and care coordination services, as well as prescriptions and limited over-the-counter drugs, medical equipment, and behavioral health and abuse services. This segment also offers various individual, small group, and large group commercial healthcare products to employers and directly to members. The company's Specialty Services segment provides pharmacy benefits management services; nurse advice line and after-hours support services; vision and dental services, as well as staffing services to correctional systems and other government agencies; and services to Military Health System eligible beneficiaries. This segment offers its services and products to state programs, correctional facilities, healthcare organizations, employer groups, and other commercial organizations. The company provides its services through primary and specialty care physicians, hospitals, and ancillary providers. Centene Corporation was founded in 1984 and is headquartered in St. Louis, Missouri.
Latest News & Analysis
Centene Corporation Faces Legal Challenges Amid Q2 Financial Collapse and Guidance Withdrawal
Centene Corporation's Q2 2025 financial collapse and withdrawn guidance trigger securities fraud lawsuits, impacting CNC stock and investor confidence.
Centene Corporation (CNC) Q2 2025 Earnings Miss and Securities Fraud Lawsuit Impact Analysis
Centene's Q2 2025 earnings miss triggers securities fraud lawsuit amid inflated guidance claims and a sharp stock drop, reshaping investor outlook.
Centene Corporation (CNC) Fraud Lawsuit and Financial Impact Analysis
Explore Centene Corporation's recent securities fraud lawsuit, 40% stock plunge, and financial performance analysis with investor deadlines and strategic insights.
Centene Corporation (CNC) Latest Market Analysis: Legal Challenges and Financial Performance Impact
Centene Corporation faces securities fraud lawsuits amid guidance withdrawal and stock decline; comprehensive analysis of financials, legal risks, and market positioning.
Centene Corporation (CNC) Update: Securities Fraud Allegations and Financial Impact Analysis
Centene faces securities fraud allegations amid a stock collapse. This data-driven analysis examines the financial fallout, legal developments, and investor implications.
Centene Corporation (CNC) Latest Legal Challenges and Financial Performance Analysis
Centene faces a securities fraud class action lawsuit amid operational challenges and strong financial metrics. Explore CNC's stock impact and strategic outlook.
Centene Corporation (CNC) Legal Turmoil and Financial Review: Implications for Investors
Centene Corporation faces securities fraud allegations impacting stock and fundamentals. Explore the financial metrics and legal developments shaping investor decisions.
Centene Corporation (CNC) Latest Market Analysis: Navigating Medicaid Cuts and Legal Risks
Centene Corporation faces significant headwinds from Medicaid funding cuts, rising morbidity costs, and legal challenges impacting earnings and stock performance.
Centene Corporation Stock Plunge and Guidance Withdrawal: A Data-Driven Financial Analysis
Centene's 40% stock plunge follows its 2025 guidance withdrawal due to higher morbidity and lower growth. Explore the financial impact, market reaction, and strategic outlook.
Centene Corporation: Navigating a $1.8B Risk Adjustment Shortfall and Medicaid Cost Pressures
Centene Corp withdraws 2025 guidance amid a $1.8B risk adjustment shortfall and rising Medicaid costs, highlighting sector-wide challenges and legal risks.
Centene Corporation Faces $1.8B ACA Shortfall, Guidance Withdrawal, and Market Shock
Centene's $1.8B ACA risk adjustment shortfall triggers 2025 guidance withdrawal and securities fraud probes, causing sharp stock decline and sector-wide implications.
Centene Corporation Financial Analysis: Q1 2025 Earnings & Strategic Outlook
Centene's Q1 2025 earnings show strong Medicare growth amid Medicaid challenges, with solid financials and analyst confidence shaping a promising outlook.
Centene Corporation (CNC): Strong Q1 & Strategic Initiatives Analysis
Centene Corporation's stock dips slightly despite strong Q1 2025 earnings and bullish analyst upgrades, signaling a complex market dynamic.
Centene Corporation (CNC): Strategic Resilience Amidst Policy Crosscurrents
Centene's Q1 2025 earnings beat expectations, yet its stock dipped, highlighting market grappling with policy uncertainties despite robust operational gains.
Centene (CNC) Financials: Cash Flow Puzzle Amidst Strategic Growth
Centene (CNC) faces a cash flow puzzle despite earnings growth. A deep dive into FY2024 financials, strategic Nevada contract win, and Medicaid redeterminations.
Centene (CNC): Illinois Expansion, Financial Impact, and Q1 Preview
Centene expands in Illinois with a D-SNP contract, impacting membership and revenue. Q1 2025 earnings preview and strategic analysis.
Centene (CNC): Illinois Contract, Rising Costs, Community Impact
Analysis of Centene Corporation's (CNC) recent Illinois contract, cost management strategies, community investments, and conference participation. Examines financial impact and market position.
Centene Corporation: Q4 Earnings, Strategic Appointments, and Market Outlook
Centene Corporation navigates a dynamic healthcare landscape with Q4 earnings beat, strategic appointments, and community investments, impacting its market position.
Centene (CNC): Q4 Earnings, Market Trends, and Strategic Outlook
Centene (CNC) Q4 earnings beat expectations, driven by membership growth. Rising medical costs and Medicaid changes pose challenges, but community investments offer long-term value.
Centene (CNC) Q4 2024 Earnings Analysis: Growth, Challenges, and Outlook
Centene (CNC) Q4 2024 earnings beat expectations, driven by membership growth. Rising medical costs and policy changes present challenges. Community investment and ICHRA are key strategies.
Centene (CNC) Q4 2024 Earnings: Analysis and 2025 Outlook
Centene's Q4 2024 earnings beat estimates, but rising medical costs and Medicaid challenges loom. Strategic adjustments and community investments are key.
Centene (CNC): Q4 Earnings, 2025 Outlook, and Strategic Analysis
Centene (CNC) Q4 earnings beat estimates, driven by membership growth and strategic ACA marketplace expansion. Key takeaways and strategic implications inside.
Centene (CNC) Q4 Earnings: Commercial Growth Offsets Medicaid Decline
Centene Corporation's Q4 2024 results beat estimates with robust commercial growth offsetting Medicaid declines, paving a strong path for 2025.
Centene Corporation: Earnings Beat, Growth Strategy, and Market Outlook
Centene Corporation (CNC) reports strong Q4 2024 earnings, driven by commercial plan growth and strategic community investments, signaling robust market positioning.
Centene Corporation Q4 Earnings: Membership Growth Fuels Strong Results
Centene Corporation's Q4 2024 earnings beat estimates, driven by membership growth and strength in commercial health insurance plans, setting a positive tone for 2025.
Centene (CNC) Q4 2024 Earnings: Membership Growth Drives Strong 2025 Outlook
Centene Corporation’s Q4 2024 earnings exceeded expectations with robust membership growth and a promising 2025 outlook.